NCT05353725已完成不适用
Extracorporeal Membrane Oxygenation in COVID-19, Influenza and ARDS of Other Ethiologies
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 主要终点
- 180-day survival
研究概览
简要总结
A comparison of clinical characteristics and outcomes of patients on extracorporeal membrane oxygenation (ECMO) in COVID-19, influenza and ARDS of other ethiologies
详细描述
All ARDS patients on extracorporeal membrane oxygenation (ECMO) during January 1st 2016 and January 10th 2022 in University Medical Center Ljubljana were included and their clinical characteristics and outcomes were studied according to ARDS ethiology: COVID-19, influenza and other ethiologies.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient with acute respiratory distress syndrome (ARDS) on extracorporeal membrane oxygenation (ECMO)
- •18 years or older
排除标准
- •Patient not eligible for ECMO treatment per institutional guidelines (terminal illness, palliative care)
结局指标
主要结局
180-day survival
时间窗: From day of ECMO-implant for every 24 hours until date of death or survival at 180 days
180-day survival from ECMO implantation
次要结局
- Weaning from ECMO(From day of ECMO-implant until date of death or weaning)
- ICU survival(From day of ICU-admission for every 24 hours until date of death or survival at ICU discharge)
- 90-day survival(From day of ECMO-implant for every 24 hours until date of death or survival at 90 days)
- Days on ECMO(From day of ECMO-implant for every 24 hours until date of weaning or death)
- Hospital survival(From day of hospital admission for every 24 hours until date of death or survival at hospital discharge)
- 30-day survival(From day of ECMO-implant for every 24 hours until date of death or survival at 30 days)
- ICU length of stay(From day of ICU-admission for every 24 hours until date of death or date of ICU discharge)
研究者
Jernej Berden, MD, PhD
Deputy Head of Department of Internal Intensive Care Medicine
University Medical Centre Ljubljana
相似试验
已完成
不适用
Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress SyndromeCOVID-19Extracorporeal Membrane Oxygenation ComplicationAcute Respiratory Distress SyndromeNCT04383678Helsinki University Central Hospital132
已完成
不适用
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19COVID-19NCT05158816Jessa Hospital295
已完成
不适用
Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2Acute Refractory Heart Failure Related to SARS-CoV 2NCT04397588Rennes University Hospital761
已完成
不适用
Extracorporeal Membrane Oxygenation Effect in Prolonged Cardiopulmonary ResuscitationCardiopulmonary ResuscitationVentricular FibrillationCardiac ArrestVentricular TachycardiaNCT00173615National Taiwan University Hospital100
Unknown
不适用
Long Term Outcome of Extracorporeal Membrane Oxygenation Patients in ChinaLong-term OutcomeExtracorporeal Membrane OxygenationNCT03345758Southeast University, China80